Trial :

Motor Neurone Disease

Age :

18 - 65 years

Trial length :

15 nights

Info :

1 follow up visit

We are conducting a study for a potential treatment of Amyotrophic Lateral Sclerosis (ALS).

 

Motor Neurone Disease or Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder, marked by early peripheral “dying back or Wallerian-like” denervation and axonal degeneration, ultimately resulting in loss of cell bodies of motor neurons.

While a couple of therapies are approved for the treatment of ALS, there are no approved disease-modifying therapies that address the underlying degenerative mechanisms.

 

To be eligible for this study, you must fit the following criteria:

  • Healthy Males aged 18 to 65
  • Healthy Post Menopausal Females aged up to 65
  • Body mass index (BMI) within the range 18 to 30 kg/m2

 

This study requires 15 nights / 16 days stay in our facility, with 1 follow-up visit.

We are located in Randwick, near numerous bus stops and adjacent to the last light rail stop.

Our facility is first-class, with showers, a well-equipped recreation room, numerous TV screens, games consoles, books, board games and a quiet room with desktop computers.

All meals are included in your stay, including vegetarian options and there is free WiFi to keep you connected and even views of the ocean down at Coogee Beach…and you are sure to meet new people and make new friends!

 

If you meet the criteria for this study and would like more information, please register using the button below or call/email our Recruitment Team on 1800 727 874 or email us recruitment@scientiaclinicalresearch.com.au

We look forward to seeing you!